Plenary Lecture. Diet and cancer prevention: The Concerted Action Polyp Prevention (CAPP) studies

Proceedings of the Nutrition Society

Volumn 57, Issue 2, 1998, Pages 183-186

  Burn, J ^a   Chapman, P D ^a   Bishop, D T ^b   Mathers, J ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; NONSTEROID ANTIINFLAMMATORY AGENT; STARCH;

AGED; CARBOHYDRATE DIET; COLORECTAL TUMOR; DIET; GENETICS; HUMAN; REVIEW;

AGED; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASPIRIN; COLORECTAL NEOPLASMS; DIET; DIETARY CARBOHYDRATES; HUMANS; STARCH;

EID: 0032060975     PISSN: 00296651     EISSN: None     Source Type: Journal    
DOI: 10.1079/pns19980030     Document Type: Article

References (34)

1. Bingham SA (1988) Meat, starch and nonstarch polysaccharides and large bowel cancer. American Journal of Clinical Nutrition 48, 762-767.
2. Boolbol SK, Dannanberg AJ, Chadburn A, Martucci C, Guo X, Ramonetti JT, Abreu-Goris M, Newmark HL, Lipkin M, DeCosse JJ & Bertagnolli MM (1996) Cyclooxygenase-2 overexpression and tumor formation are blocked by sulindac in a murine model of Familial Adenomatous Polyposis. Cancer Research 56, 2556-2560.
3. Burkitt DP (1969) Related disease-related cause. Lancet ii, 1229-1231.
4. Burn J, Chapman PD, Bertario L, Bishop DT, Bülow S, Cummings J, Mathers J, Phillips R & Vasen H (1995) A European double-blind trial of aspirin and resistant starch in Familial Adenomatous Polyposis: The CAPP Study. European Journal of Cancer 31A, 1385-1386 Abstr.
5. Burn J, Chapman PD & Eastham EJ (1994) Familial Adenomatous Polyposis. Archives of Disease in Childhood 71, 103-107.
6. Cassidy A, Bingham SA & Cummings JH (1994) Starch intake and colorectal cancer risk: an international comparison. British Journal of Cancer 69, 937-942.
7. Davis AE & Patterson F (1994) Aspirin reduces the incidence of colonie carcinoma in the dimethylhydrazine rat animal model. Australian and New Zealand Journal of Medicine 24, 301-303.
8. Debinski HS, Trojan J, Nugent KP, Spigelman AD & Phillips RKS (1995) Effect of sulindac on small polyps in familial adenomatous polyposis. Lancet 345, 855-856.
9. Delaney TP, Uknes S, Vernooij B, Friedrich J, Weymann K, Negrotto T, Gaffney T, Gut-Rella M, Kessmann H, Ward E & Ryals J (1994) A central role of salicylic acid in plant disease resistance. Science 266, 1247-1250.
10. Dunlop MG, Farrington SM, Carothers AD, Wyllie AH, Sharp L, Burn J, Liu B, Kinzler KW & Vogelstein B (1997) Cancer risk associated with germline DNA mismatch repair gene mutations. Human Molecular Genetics 6, 105-110.
11. Elder DJE, Hague A, Hicks DJ & Paraskeva C (1996) Differential growth inhibition by the aspirin metabolite salicylate in human colorectal tumor cell lines: enhanced apoptosis in carcinoma and in vitro-transformed adenoma relative to adenoma cell lines. Cancer Research 56, 2273-2276.
12. Giardiello FM (1994) Sulindac and polyp regression. Cancer and Metastasis Reviews 13, 279-283.
13. Giovannucci E, Egan KM, Hunter DJ, Stampfer MJ, Colditz GA, Willett WC & Speizer FE (1995) Aspirin and the risk of colorectal cancer in women. New England Journal of Medicine 333, 609-614.
14. Giovannucci E, Rimm EB, Stampfer MJ, Colditz GA, Asherio A & Willett WC (1994) Aspirin use and the risk for colorectal cancer and adenoma in male health professionals. Annals of Internal Medicine 121, 241-246.
15. Hague A, Manning AM, Hanlon KA, Huschtscha LI, Hart D & Paraskeva C (1993) Sodium butyrate induces apoptosis in human colonic tumour cell lines in a p53-independent pathway. Implications for the possible role of dietary fibre in the prevention of large-bowel cancer. International Journal of Cancer 55, 498-505.
16. Janssen K, Hollman PC, Reichman E, Venema DP, van Staveren WA & Katan MB (1996) Urinary salicylate excretion in subjects eating a variety of diets shows that amounts of bioavailable salicylates in foods are low. American Journal of Clinical Nutrition 64, 743-747.
17. Järvinen HJ, Mecklin JP & Sistonen P (1995) Screening reduces colorectal cancer rate in families with hereditary nonpolyposis colorectal cancer. Gastroenterology 108, 1405-1411.
18. Kolodner RD, Hall NR, Lipford J, Kane MF, Rao MRS, Morrison P, Wirth L, Finan PJ, Burn J, Chapman P, Earabino C, Merchant E, Bishop DT, Garber J, Bronner CE, Baker SM, Warren G, Smith LG, Lindblom A, Tannergard P, Bollag RJ, Godwin AR, Ward DC & Nordenskjold M (1994) Human mismatch repair genes and their association with hereditary non-polyposis colon cancer. Cold Spring Harbor Symposia in Quantitative Biology 59, 331-338.
19. Kruh J, Tichonicky L & Defer N (1994) Effect of butyrate on gene expression. In Short Chain Fatty Acids, pp. 135-147 [HJ Binder, J Cummings and KH Soergel, editors]. Lancaster: Kluwer Academic Publishers.
20. Kune GA, Kune S & Watson LF (1988) Colorectal cancer risk, chronic illness, operations, medications: case control results from the Melbourne Colorectal Cancer Study. Cancer Research 48, 4399-4404.
21. Leutwyler K (1994) Something to chew on. Scientific American 270, 13.
22. McIntyre A, Gibson PR & Young GP (1993) Butyrate production from dietary fibre and protection against large bowel cancer in a rat model. Gut 34, 386-391.
23. δ716 knockout mice by inhibition of cyclooxygenase 2 (COX-2). Cell 87, 803-809.
24. Paganini-Hill A, Chao A, Ross RK & Henderson BE (1989) Aspirin use and chronic diseases: a cohort study of the elderly. British Medical Journal 299, 1247-1249.
25. Peleg II, Maibach HT, Brown SH & Wilcox M (1994) Aspirin and nonsteroidal anti-inflammatory drug use and the risk of subsequent colorectal cancer. Archives of Internal Medicine 154, 394-399.
26. Piazza GA, Kulchak Rahm AL, Krutzsch M, Sperl G & Shipp Paranka N (1995) Antineoplastic drugs sulindac sulfide and sulfone inhibit cell growth by inducing apoptosis. Cancer Research 55, 3110-3116.
27. Rosenberg L, Palmer JR, Zauber AG, Warshauer ME, Stolley PD & Shapiro S (1991) A hypothesis: nonsteroidal anti-inflammatory drugs reduce the incidence of large bowel cancer. Journal of the National Cancer Institute 83, 355-359.
28. Scheppach W (1994) Effects of short chain fatty acids on gut morphology and function. Gut 35, S35-S38.
29. Schreinemachers DM & Everson RB (1994) Aspirin use and lung, colon, and breast cancer incidence in a prospective study. Epidemiology 5, 138-146.
30. Sniff SJ, Koutsos MI, Qiao L & Rigas B (1996) Nonsteroidal antiinflammatory drugs inhibit the proliferation of colon adenocarcinoma cells: effects on cell cycle and apoptosis. Experimental Cell Research 222, 179-188.
31. Stephenson BM, Finan PJ, Gasgoyne J, Garbett F, Murday VA & Bishop DT (1991) Frequency of familial colorectal cancer. British Journal of Surgery 78, 1162-1166.
32. Suh O, Mettlin C & Petrelli NJ (1993) Aspirin use, cancer and polyps of the large bowel. Cancer 72, 1171-1177.
33. Thun MJ, Namboodiri MM & Heath CW Jr (1991) Aspirin use and reduced risk of fatal colon cancer. New England Journal of Medicine 325, 1593-1596.
34. van Munster IP, Tangerman A & Nagengast FM (1994) Effect of resistant starch on colonie fermentation, bile acid metabolism, and mucosal proliferation. Digestive Diseases and Sciences 39, 834-842.